The Royal College of Radiologists (RCR) welcomed British Prime Minister Theresa May’s recent declaration to focus on early detection of cancer, though the organization is questioning how a step-change will be achieved without funding for more radiologists and clinical oncologists, according to an RCR press release published Oct. 3.

GE Healthcare still plans to separate into an independent company after General Electric named a new chairman and CEO, according to a report by CNBC.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is urging the U.S. Congress to pass H.R. 6948, which would keep the pass-through status for diagnostic radiopharmaceuticals under Medicare reimbursement.

The National Institutes of Health (NIH) released in the Journal of the American Medical Association on Sept. 26, a new strategic plan for tuberculosis (TB) aiming to strengthen research, diagnostic tools and clinical efforts to tackle the disease, according to a NIH news release.

As the trade war between the U.S. and China continues, the medical technology industry is bracing for heavy impact from China's $5 billion in tariffs on imported U.S. goods—including medical imaging devices and technology, according to an article published Sept. 24 by Forbes.

The Medical Imaging and Technology Alliance (MITA) commended the U.S. Senate for including a bipartisan provision in the Opioid Crisis Response Act of 2018 to facilitate the development of ultrasound technologies as an alternative to using opioids for pain management.

The International Contrast Ultrasound Society (ICUS) has urged the U.S. FDA to remove boxed warnings from ultrasound contrast agents based on research demonstrating its safety and clinical benefits.

MRI has become a central part of diagnosing and managing prostate cancer, but private payer coverage has not kept up with this technological trend, reported authors of a recent Journal of the American College of Radiology study.